Preserving the national blood supply

Area of Science:

• Hematology
• Public Health
• Transfusion Medicine

Background:

• National blood supply faces increasing demand and declining donation rates.
• Enhanced screening and testing procedures contribute to donor loss.
• Iron status of donors is a key factor in blood availability.

Purpose of the Study:

• To examine strategies for augmenting the blood supply through iron status management.
• To explore the use of blood from individuals with hereditary hemochromatosis.
• To assess iron supplementation's role in retaining female blood donors.

Main Methods:

• Review of factors affecting donor eligibility and retention.
• Analysis of US Food and Drug Administration (FDA) recommendations on blood collection from hereditary hemochromatosis patients.
• Evaluation of low-dose carbonyl iron supplementation for women of childbearing age.

Main Results:

• Hereditary hemochromatosis offers a potential source of blood units.
• Iron supplementation can prevent iron deficiency in female donors, improving retention.
• Iron-related interventions can enhance donor recruitment and commitment.

Conclusions:

• Optimizing donor iron status is crucial for maintaining an adequate blood supply.
• Therapeutic phlebotomy in hereditary hemochromatosis and iron supplementation are viable strategies.
• Proactive management of donor iron levels can mitigate blood shortages.